deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT02229123

Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study (LEVNEONAT-1)

Levetiracetam Efficacy and Safety as First-line Treatment of Neonatal Seizures Occuring in Hypoxic-ischemic Encephalopathy Context

Sponsor: Amiens University Hospital

Conditions Neonatal Seizures
Interventions Intravenous Levetiracetam
Updated 13 times since 2017 Last updated: Dec 23, 2025 Started: Feb 27, 2018 Primary completion: Feb 23, 2022 Completion: Feb 23, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Neonatal Seizures and is currently completed. Amiens University Hospital leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Mar 2018 · 14 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Apr 2020 · 21 months · monthly snapshot~Apr 2020 – ~Dec 2020 · 8 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshot~Dec 2022 – ~Mar 2024 · 15 months · monthly snapshot~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshot~Jan 2026 – present · 7 months · monthly snapshot

Change History

13 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed PHASE2

  2. Sep 2025 — Jan 2026 [monthly]

    Completed PHASE2

  3. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  5. Mar 2024 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

▶ Show 8 earlier versions

  1. Dec 2022 — Mar 2024 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  2. Jan 2021 — Dec 2022 [monthly]

    Recruiting PHASE2

  3. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Unknown Status → Recruiting

  4. Apr 2020 — Dec 2020 [monthly]

    Unknown Status PHASE2

    Status: Recruiting → Unknown Status

  5. Jul 2018 — Apr 2020 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE2

  7. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

    Status: Unknown Status → Recruiting

  8. Jan 2017 — Mar 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Amiens University Hospital
  • Assistance Publique - Hôpitaux de Paris
  • Rennes University Hospital
  • University Hospital, Tours
Data source: University Hospital, Tours

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations